Screening for kidney cancer: Is there a role for aquaporin-1 and adipophilin

Mayo Clinic Proceedings

Volumn 85, Issue 5, 2010, Pages 410-412

  Grebe, Stefan K ^a   Erickson, Lori A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; AQUAPORIN 1; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; CANCER SIZE; CLEAR CELL CARCINOMA; DIAGNOSTIC TEST; EDITORIAL; EXOSOME; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; KIDNEY; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; KIDNEY SURGERY; KIDNEY TUMOR; PROGNOSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 77951737381     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0165     Document Type: Editorial

References (13)

1. Morrissey JJ, London AN, Luo J, Kharasch ED. Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin Proc. 2010;85(5):413-421.
2. Marples D, Frøkiaer J, Nielsen S. Long-term regulation of aquaporins in the kidney. Am J Physiol. 1999;276(3, pt 2):F331-F339.
3. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 1998;294(2):309-321. (Pubitemid 28486407)
4. Verkman AS. Aquaporins: translating bench research to human disease. J Exp Biol. 2009;212:1707-1715.
5. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol. 2005;18:535-540. (Pubitemid 40478117)
6. Yao M, Huang Y, Shioi K, et al. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer Res. 2007;13:152-160. (Pubitemid 46121864)
7. Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins - new players in cancer biology. J Mol Med. 2008;86:523-529.
8. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569-579.
9. Sonoda H, Yokota-Ikeda N, Oshikawa S, et al. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2009;297:F1006-F1016.
10. Esteva-Font C, Baccaro ME, Fernandez-Llama P, et al. Aquaporin-1 and Aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome. Hepatology. 2006;44:1555-1563. (Pubitemid 44953660)
11. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611-1623.
12. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
13. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302:1685-1692.